Cargando…
Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
KRAS mutations are major factors involved in initiation and maintenance of pancreatic tumors. The impact of different mutations on patient survival has not been clearly defined. We screened tumors from 171 pancreatic cancer patients for mutations in KRAS and CDKN2A genes. Mutations in KRAS were dete...
Autores principales: | Rachakonda, P. Sivaramakrishna, Bauer, Andrea S., Xie, Huaping, Campa, Daniele, Rizzato, Cosmeri, Canzian, Federico, Beghelli, Stefania, Greenhalf, William, Costello, Eithne, Schanne, Michaela, Heller, Anette, Scarpa, Aldo, Neoptolemos, John P., Werner, Jens, Büchler, Markus, Hoheisel, Jörg D., Hemminki, Kari, Giese, Nathalia, Kumar, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614935/ https://www.ncbi.nlm.nih.gov/pubmed/23565280 http://dx.doi.org/10.1371/journal.pone.0060870 |
Ejemplares similares
-
Pancreatic Cancer Susceptibility Loci and Their Role in Survival
por: Rizzato, Cosmeri, et al.
Publicado: (2011) -
Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer
por: Bauer, Andrea S., et al.
Publicado: (2017) -
Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue
por: Bauer, Andrea S., et al.
Publicado: (2012) -
Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts
por: Xie, Huaping, et al.
Publicado: (2016) -
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
por: Hemminki, Kari, et al.
Publicado: (2020)